Registered entities
Amplyx Pharmaceuticals Inc
Reg. No. 20-4563467United States
Investor mix
18 investors on record; lead investors include 3x5 Partners, Sofinnova Investments, RiverVest Venture Partners; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 61% |
| Private equity | 1 | 6% |
| Angel & family office | 3 | 17% |
| Other / undisclosed | 3 | 17% |